Market News & Trends
Cyclacel Announces Phase II Trial of Sapacitabine
Cyclacel Pharmaceuticals, Inc. recently announced that the first patient has been dosed in an investigator-initiated, translational, Phase II clinical study at The University of Texas…
8/30/2011
Avantor Performance Materials Expands Portfolio Avantor Performance Materials recently announced it has expanded its portfolio by offering cGMP-manufactured Methylene Chloride and Acetone produced at its…
apceth Starts First Phase I/II Clinical Study on Somatic Cell Therapy for pAOD
The Munich biotech company apceth recently announced it started its first Phase I/II clinical study on somatic cell therapy for advanced peripheral arterial occlusive disease…
Avantor Performance Materials Expands Portfolio
Avantor Performance Materials recently announced it has expanded its portfolio by offering cGMP-manufactured Methylene Chloride and Acetone produced at its manufacturing facility in Phillipsburg, NJ.…
Bend Research & Xcelience Form Partnership to Speed Drug Product Intermediates to Early Phase Clinical Trials
Bend Research Inc. and Xcelience LLC recently announced they have formed a collaboration to provide oral solid-solubilization formulation solutions and expedited clinical supply manufacture in…
Rexam Healthcare Receives 510(k) FDA Approval
Rexam Healthcare recently announced it has received 510(k) approval from the Food and Drug Administration (FDA) for Safe'n'Sound, its passive safety device for staked prefilled…
Tekmira Acquires Worldwide Exclusive License to Novel RNAi Platform
Tekmira Pharmaceuticals Corporation recently announced it has obtained an exclusive, worldwide license to a novel and proprietary RNAi technology called MV-RNA (multivalent RNA) from Halo-Bio…
Unilife Develops Multiple-Chamber Prefilled Syringes
Unilife Corporation recently announced the development and patenting of the Unifill EZMix multiple-chamber ready-to-fill (prefilled) syringes. Unifill EZMix syringes have been developed in direct response…
Evonik Establishes New Health Care Business Line
Evonik Industries AG recently announced it will combine its business in custom manufacturing of APIs (exclusive synthesis), pharmaceutical amino acids (Rexim) and pharmaceutical polymers in…
Intellipharmaceutics & Par Pharmaceutical Expand Development & Commercialization Agreement
Intellipharmaceutics International Inc. recently announced that they have added the development and commercialization of additional strengths of generic Focalin XR (dexmethylphenidate hydrochloride) for the US…
Xcelience to Expand, Plans to Hire 45 Employees
Xcelience, a Tampa, FL-based contract research organization, recently announced it is expanding its footprint and more than doubling its employment over the next 3 years.…
8/23/2011
Intellipharmaceutics & Par Pharmaceutical Expand Development & Commercialization Agreement Intellipharmaceutics International Inc. recently announced that they have added the development and commercialization of additional strengths…
Alexza Pharmaceuticals Announces PDUFA Goal Date
Alexza Pharmaceuticals, Inc. recently announced the US FDA has accepted the ADASUVE NDA as a complete, class 2 response to the FDA's action letter, with…
DARA BioSciences Receives Fast-Track Designation for KRN5500
DARA BioSciences, Inc. recently announced its investigational drug KRN5500 has been granted Fast-Track designation by the US FDA for the treatment of chemotherapy-induced neuropathic pain…
Encap Drug Delivery Introduces Colon-Screen
Encap Drug Delivery recently announced it is now offering a feasibility package that will evaluate the potential to use candidate compounds in formulations suitable for…
8/16/2011
Boehringer Ingelheim Licenses ProBioGen's GlymaxX Technology Boehringer Ingelheim and ProBioGen AG recently announced they have signed a non-exclusive Licensing Agreement regarding ProBioGen's GlymaxX technology.…
Affymax Receives $10-Million Milestone Payment From Takeda
Affymax, Inc. recently announced it has received a $10-million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to…
Array BioPharma, Genentech Ink $713 Million Oncology Pact
Array BioPharma recently announced an oncology agreement with Genentech, a member of the Roche Group, for the development of each company's small-molecule Checkpoint kinase 1…
Boehringer Ingelheim Licenses ProBioGen's GlymaxX Technology
Boehringer Ingelheim and ProBioGen AG recently announced they have signed a non-exclusive Licensing Agreement regarding ProBioGen's GlymaxX technology. Boehringer Ingelheim's Contract Manufacturing Business will apply…
Bohai Pharmaceuticals Acquires Yantai Tianzheng Pharma for $35 Million
Bohai Pharmaceuticals Group, Inc. recently announced it has consummated a significant acquisition of a complementary Traditional Chinese Medicine (TCM) company in China, Yantai Tianzheng Pharmaceutical…
